Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China flag China · Delayed Price · Currency is CNY
16.94
+0.46 (2.79%)
At close: Mar 6, 2026

SHA:688488 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,1286,8713,3075,2644,4276,539
Market Cap Growth
124.67%107.76%-37.17%18.91%-32.31%-37.22%
Enterprise Value
7,2957,0393,4025,1474,0845,910
Last Close Price
16.9416.337.8612.5110.5415.57
PS Ratio
9.899.547.9212.8018.1325.57
PB Ratio
6.596.353.104.683.694.99
P/TBV Ratio
11.0310.635.225.284.145.60
EV/Sales Ratio
10.129.778.1412.5116.7223.11
EV/EBITDA Ratio
76.6373.94----
EV/EBIT Ratio
152.80147.42----
Debt / Equity Ratio
0.450.450.460.370.170.00
Debt / EBITDA Ratio
5.095.09----
Net Debt / Equity Ratio
0.060.060.04-0.03-0.23-0.46
Net Debt / EBITDA Ratio
0.670.67-0.450.452.0117.11
Net Debt / FCF Ratio
---0.570.121.195.60
Asset Turnover
--0.230.240.160.18
Inventory Turnover
--1.021.441.271.79
Quick Ratio
--0.931.321.877.52
Current Ratio
--1.381.782.428.94
Return on Equity (ROE)
-1.84%-1.84%-12.66%-6.54%-9.89%-2.25%
Return on Assets (ROA)
---5.24%-3.90%-6.94%-2.70%
Return on Invested Capital (ROIC)
-3.38%-3.43%-13.71%-10.53%-21.05%-9.64%
Return on Capital Employed (ROCE)
---12.40%-8.50%-13.00%-4.60%
Earnings Yield
-0.28%-0.29%-4.27%-1.44%-2.80%-0.46%
FCF Yield
---2.48%-4.51%-5.26%-1.64%
Buyback Yield / Dilution
4.97%6.20%0.44%-2.17%3.44%-7.71%
Total Shareholder Return
4.97%6.20%0.44%-2.17%3.44%-7.71%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.